SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 4.41 |
Enterprise Value ($M) | 4.70 |
Book Value ($M) | 3.73 |
Book Value / Share | 1.89 |
Price / Book | 1.18 |
NCAV ($M) | -5.51 |
NCAV / Share | -2.79 |
Price / NCAV | -0.80 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.74 |
Return on Assets (ROA) | -0.63 |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.19 |
Current Ratio | 0.19 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 1.23 |
Assets | 10.47 |
Liabilities | 6.74 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Nonrecurring Common Control Intra Entity Transactions Description | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Armistice Capital, Llc | 4.99 | -95.15 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
18,600 | 91,767 | 20.27 | |
7,174 | 41,875 | 17.13 | |
15,961 | 77,912 | 20.49 | |
135,032 | 407,898 | 33.10 | |
(click for more detail) |
Similar Companies | |
---|---|
ARTL – Artelo Biosciences, Inc. | ASNS – Actelis Networks, Inc. |
ASRT – Assertio Holdings, Inc. | ATOS – Atossa Therapeutics, Inc. |
ATXI – Avenue Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io